Spironolactone
In brief
- In our pharmacy, you can buy spironolactone without a prescription, with delivery in 9–21 days throughout the United Kingdom; discreet and anonymous packaging is available.
- Spironolactone is used for oedema (heart failure, cirrhosis, nephrotic syndrome), hypertension, primary aldosteronism, hypokalaemia prevention, and off‑label for acne and hirsutism; it is a potassium‑sparing diuretic that antagonises aldosterone receptors in the distal nephron and has antiandrogenic effects.
- Usual adult doses vary by indication: 25–100 mg/day for hypertension, 100 mg/day (range 25–200 mg/day) for oedema, 12.5–50 mg/day as adjunct in heart failure, and 50–200 mg/day for acne/hirsutism; paediatric dosing is typically 1–3 mg/kg/day under specialist supervision.
- The form of administration is oral: tablets (commonly 25 mg, 50 mg, 100 mg), sometimes compounded oral suspensions, and combination tablets with thiazides.
- The onset of diuretic effect is relatively slow: initial effects may be seen within 24–72 hours, whereas hormonal/antiandrogenic benefits (e.g. for acne) take several weeks to months to appear.
- The duration of action for diuresis is generally 24–72 hours due to active metabolites; clinical effects persist with ongoing therapy and antiandrogenic effects require continuous treatment.
- Avoid excessive alcohol: alcohol may increase dizziness, dehydration and hypotension risk and can worsen liver disease or other side effects when taking spironolactone.
- The most common significant side effect is hyperkalaemia.
- Would you like to try spironolactone without a prescription?
Basic spironolactone information
- INN (international nonproprietary name): spironolactone
- Brand names available in the United Kingdom: Aldactone; Aldactide (spironolactone with hydroflumethiazide); generic spironolactone
- ATC code: C03DA01
- Forms and dosages: Tablets 25 mg, 50 mg, 100 mg; oral suspension (less common); combination tablets with hydroflumethiazide (25 mg/25 mg, 50 mg/50 mg)
- Manufacturers in the United Kingdom: Pfizer (Aldactone) and generic manufacturers
- OTC / Rx classification: Prescription-only medicine (POM)
Critical warnings and restrictions (safety first)
High‑risk groups (elderly, pregnancy, chronic illness)
Are you worried spironolactone will be unsafe for you?
Start here: spironolactone is a prescription‑only medicine and must not be started without baseline renal function and serum potassium measurements.
Absolute contraindications include acute renal failure, anuria, known hypersensitivity, Addison’s disease (adrenal insufficiency) and hyperkalaemia.
Before initiation, use a monitoring checklist to protect the patient immediately.
- Baseline checks: U&Es (serum potassium, sodium), eGFR/creatinine.
- Pregnancy test: for women of childbearing potential where relevant.
- Drug history review: ACE inhibitors, ARBs, potassium supplements, NSAIDs and other interacting drugs.
Elderly patients should start at the lower end of dosing and be monitored more frequently because of the higher risk of hyperkalaemia and postural hypotension.
Hepatic impairment requires caution and closer monitoring of fluid and electrolytes.
Interaction with activities (driving, workplace safety under UK law)
Will spironolactone affect your ability to work or drive?
Dizziness and drowsiness are reported side effects and can affect driving or operating machinery.
If a patient experiences light‑headedness, fainting or visual disturbance after starting spironolactone, they must avoid driving and heavy machinery until symptoms settle.
Advise employers or occupational health when required by workplace policy if tasks require full alertness.
Q&A — “Can I drive after taking it in the UK?”
Short answer: If you feel drowsy, dizzy or faint, do not drive.
Report new or worrying side effects to your GP or pharmacist and consider recording them on the MHRA Yellow Card scheme.
Arrange follow‑up blood tests if advised by the prescriber, and obtain occupational advice if your job requires driving or safety‑critical duties.
- Checklist for monitoring: baseline U&Es and eGFR, potassium at 1–2 weeks after start or dose change, then at 1 month and as clinically indicated.
- When to seek urgent help: fainting, severe dizziness, new palpitations, muscle weakness.
Usage basics
INN, brand names available in the UK
What is spironolactone called and what might you be given?
The International Nonproprietary Name (INN) is spironolactone.
In UK supplies you may find Aldactide as a combination product; generic spironolactone tablets are commonly supplied in strengths 25 mg, 50 mg and 100 mg.
Packaging is typically blister packs or bottles, and combo tablets may include a thiazide‑type agent such as hydroflumethiazide.
Legal classification (POM, P, GSL)
Is a prescription needed?
Spironolactone is classified as a prescription‑only medicine (POM) in the UK.
Dispensing follows NHS prescription rules; private prescriptions are accepted in community pharmacies.
What to bring to the pharmacy:
- Valid prescription (NHS or private).
- Medication list and any monitoring results if requested.
- Photo ID if required by the pharmacy for proof of identity.
Pharmacists can provide counselling under NHS medicines services and will flag monitoring requirements when dispensing spironolactone.
Dosing guide
Standard regimens (NHS guidance)
People often ask: what dose will I be started on?
Typical adult dosages vary by indication and are established in clinical practice.
- Oedema (heart failure, cirrhosis, nephrotic): around 100 mg/day (range 25–200 mg/day).
- Hypertension: 25–100 mg/day.
- Primary aldosteronism: 100–400 mg/day for diagnostic or treatment purposes.
- Acne/hirsutism (off‑label): 50–200 mg/day.
- Heart failure adjunctive: low doses commonly 12.5–50 mg/day in some regimens.
Paediatric dosing is specialist prescribed and typically 1–3 mg/kg/day divided.
Adjustments for comorbidities
How are doses adjusted for other illnesses?
Renal impairment is a key consideration; avoid or use extreme caution if creatinine clearance is below 30 mL/min due to hyperkalaemia risk.
Elderly patients should start low and be titrated slowly with more frequent monitoring.
Hepatic impairment requires caution and close electrolyte checks.
Q&A — “What if I miss a dose?”
Take the missed dose as soon as you remember unless it is close to the next scheduled dose.
If it is near the time for the next dose, skip the missed dose and resume the normal schedule.
Do not double up doses.
- When to call the GP: repeated missed doses, symptoms of hyperkalaemia (palpitations, muscle weakness), dizziness or fainting.
Interaction chart
Food and drinks (alcohol, tea/coffee, diet habits)
Can diet or alcohol make spironolactone unsafe?
Alcohol may worsen hypotension and dizziness when combined with spironolactone.
High‑potassium diets, potassium‑containing salt substitutes (potassium chloride) and large intake of potassium‑rich foods increase the risk of hyperkalaemia.
There is no major interaction with tea or coffee, but patients should keep a consistent diet for reliable monitoring.
Common drug conflicts
Which drugs raise concern when taken with spironolactone?
| Drug | Interaction mechanism | Monitoring / action required |
|---|---|---|
| ACE inhibitors / ARBs | Combined RAAS inhibition increases hyperkalaemia risk | Check potassium and renal function at baseline, 1–2 weeks, then regularly |
| Direct renin inhibitors | Higher hyperkalaemia and renal impairment risk | Avoid combination or monitor closely; seek specialist advice |
| NSAIDs | Can reduce renal perfusion and blunt diuretic effect, raising potassium | Avoid chronic NSAID use; monitor renal function |
| Potassium supplements / salt substitutes | Directly increase serum potassium | Stop or avoid; monitor potassium closely |
| Amiloride, triamterene | Combined potassium‑sparing effect causes hyperkalaemia | Generally avoid concurrent use |
| Trimethoprim | Can raise serum potassium and impair renal function | Monitor potassium during co‑prescribing |
| Lithium | Diuretics can alter lithium levels and increase toxicity | Monitor lithium levels closely |
| Digoxin | Electrolyte disturbance (hyperkalaemia) affects digoxin toxicity | Monitor electrolytes and digoxin levels as clinically indicated |
If hyperkalaemia is suspected (weakness, numbness, palpitations), act urgently.
- Immediate actions for suspected hyperkalaemia: seek urgent care, do not self‑treat with potassium; bring medication list and recent blood tests if available.
Legal status and availability in the UK
In our online pharmacy, spironolactone is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Mechanism and pharmacology
Simplified explanation
How does spironolactone work in plain terms?
Spironolactone is an aldosterone antagonist and is classified under ATC code C03DA01 as a potassium‑sparing agent.
It blocks aldosterone receptors in the distal nephron, reducing sodium reabsorption and decreasing potassium excretion.
The net effect is modest diuresis with potassium retention, which is useful for oedema and as adjunct therapy in selected heart failure patients.
Clinical terms
Key pharmacology points to record in clinical notes.
- Active metabolites: canrenone contributes to clinical effect.
- Onset of effect: actions develop over days with clinical effects becoming clearer over weeks for diuresis and months for endocrine effects in acne/hirsutism.
Indications and off‑label uses
MHRA‑approved uses
What is spironolactone licensed to treat?
Approved uses include management of oedema associated with heart failure, cirrhosis and nephrotic syndrome, adjunct treatment for hypertension and use in primary hyperaldosteronism.
Heart failure guidelines commonly recommend low‑dose aldosterone antagonists as adjunctive therapy in selected patients.
Off‑label practices in NHS and private care
What off‑label uses are common in the UK?
Off‑label use for adult women with androgenic acne and hirsutism at doses of 50–200 mg/day is common in specialist or private dermatology clinics.
Women of childbearing potential must have contraception and pregnancy counselling documented when prescribed off‑label.
- Off‑label checklist: indication and rationale, informed consent recorded, baseline tests, monitoring schedule for electrolytes and clinical response.
Alternatives matrix
NHS prescribing alternatives (comparison table)
| Drug | Class | Potency | Endocrine effects | Monitoring frequency | Typical NHS use |
|---|---|---|---|---|---|
| Eplerenone | Aldosterone antagonist | Similar potency | Fewer hormonal effects (less gynaecomastia) | Baseline and periodic U&Es | Alternative in patients intolerant of spironolactone |
| Amiloride | Potassium‑sparing diuretic | Less potent | Minimal endocrine effects | Monitor potassium and renal function | Used if spironolactone intolerance or specific indication |
| Triamterene | Potassium‑sparing diuretic | Less potent | Minimal endocrine effects | Monitor potassium and renal function | Occasionally used in combinations |
| Hydrochlorothiazide | Thiazide diuretic | Different mechanism | Not potassium‑sparing | Monitor electrolytes, glucose | Common for hypertension/oedema where potassium loss is acceptable |
Pros and cons checklist
- Eplerenone: fewer hormone side effects.
- Amiloride/triamterene: useful when spironolactone intolerance; less anti‑aldosterone benefit.
- Thiazides: effective for blood pressure but increase potassium loss and rarely used where potassium retention is desired.
- Switching guide: consider indication, side effects, renal function and drug interactions when changing therapy.
Common questions
Will spironolactone make me gain or lose weight?
Spironolactone may reduce fluid‑related weight; it is not a weight‑loss medicine.
How long until acne improves?
For acne, expect 3–6 months for noticeable improvement when used off‑label in adult women.
Do I need contraception?
Women of childbearing potential should have pregnancy counselling; spironolactone is generally avoided in pregnancy unless advised by a specialist.
How often will I need blood tests?
Typical schedule: baseline, 1–2 weeks after initiation or dose change, then at 1 month, 3 months and as clinically indicated.
- When to seek urgent care: palpitations, muscle weakness, fainting or severe dizziness.
Registration and regulation
MHRA approval process
Is spironolactone regulated in the UK?
Spironolactone is licensed and regulated in the UK by the MHRA.
Any suspected safety signals should be reported to the MHRA using the Yellow Card scheme.
NHS prescribing framework
How is prescribing organised in UK practice?
Prescribing is initiated by a GP or hospital clinician and dispensed by community pharmacies on receipt of a valid prescription.
Electronic Prescription Service (EPS) is used widely for transfer and repeat dispensing may be arranged where appropriate.
- Documentation: record baseline monitoring, agreed lab scheduling and any shared‑care arrangements for specialists initiating therapy.
- Pharmacovigilance: encourage Yellow Card reporting for suspected adverse drug reactions.
Storage and handling
UK household storage (cold/damp climate)
How should spironolactone be stored at home?
Store at 20–25°C and protect from light and moisture.
Avoid storing tablets in bathrooms where humidity is high and do not leave medicines in cars where temperatures can fluctuate markedly.
Keep all medicines out of reach of children and pets.
Guidance from NHS and pharmacists
What should patients do with leftover medicine?
Check expiry dates and return unused or out‑of‑date medicines to a pharmacy take‑back scheme for safe disposal.
For compounded oral suspensions, follow pharmacy storage instructions closely and use within the recommended period.
- Travel tips: keep in original packaging, carry a copy of the prescription or GP letter if crossing borders, store in hand luggage avoiding extreme heat or freezing.
- Accidental ingestion: seek urgent medical advice and bring the medicine container or label if possible.
Guidelines for proper use (pharmacist and NHS patient safety)
UK pharmacist counselling style
What should a pharmacist tell a patient starting spironolactone?
Counselling should briefly cover indication, dose and timing, common and serious side effects, interactions and when to seek help.
Provide written medicine information and a clear monitoring plan, and signpost patients to NHS patient leaflets and the MHRA Yellow Card for reporting adverse effects.
NHS patient safety advice
How should monitoring and follow‑up be organised?
Give a written schedule for blood tests: baseline, early check at 1–2 weeks, then at 1 month and later as required by clinical circumstances.
Advise on diet: avoid potassium supplements and salt substitutes containing potassium, and identify high potassium foods if relevant for monitoring.
- Checklist for follow‑up: arrange lab orders, schedule appointments, document shared‑care responsibilities and place monitoring plan in the patient record.
Delivery across the United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 9–21 days |
| Manchester | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Bristol | England | 9–21 days |
| Leeds | England | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Newcastle | England | 9–21 days |
| Southampton | England | 9–21 days |
| Nottingham | England | 9–21 days |
| Brighton | England | 9–21 days |
| Norwich | England | 9–21 days |